These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 646989)
21. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition. Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152 [TBL] [Abstract][Full Text] [Related]
22. Studies of prothrombin biosynthesis in cell-free systems. 3. Regulation by vitamin K and warfarin of prothrombin biosynthesis in rat liver microsomes. Johnston MF; Olson RE J Biol Chem; 1972 Jun; 247(12):4001-7. PubMed ID: 5033399 [No Abstract] [Full Text] [Related]
23. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats. Hallak HO; Wedlund PJ Drug Metab Dispos; 1991; 19(1):278-9. PubMed ID: 1673414 [No Abstract] [Full Text] [Related]
24. Vitamin K epoxidase activity of rough and smooth microsomes from rat liver. Egeberg K; Helgeland L Biochim Biophys Acta; 1980 Feb; 627(3):225-9. PubMed ID: 7353054 [TBL] [Abstract][Full Text] [Related]
26. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity. Thijssen HH; Baars LG; Vervoort-Peters HT Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986 [TBL] [Abstract][Full Text] [Related]
27. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats. Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923 [No Abstract] [Full Text] [Related]
30. Sulfaquinoxaline inhibition of vitamin K epoxide and quinone reductase. Preusch PC; Hazelett SE; Lemasters KK Arch Biochem Biophys; 1989 Feb; 269(1):18-24. PubMed ID: 2916837 [TBL] [Abstract][Full Text] [Related]
31. Vitamin K-dependent carboxylase: increased activity in a hypoprothrombinemia state. Shah DV; Suttie JW Arch Biochem Biophys; 1978 Dec; 191(2):571-7. PubMed ID: 742892 [No Abstract] [Full Text] [Related]
32. Depression of liver microsomal vitamin K epoxide reductase activity associated with antibiotic-induced coagulopathy. Matsubara T; Touchi A; Harauchi T; Takano K; Yoshizaki T Biochem Pharmacol; 1989 Aug; 38(16):2693-701. PubMed ID: 2764989 [TBL] [Abstract][Full Text] [Related]
33. Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo. Wallin R; Martin LF Biochem J; 1987 Jan; 241(2):389-96. PubMed ID: 3593198 [TBL] [Abstract][Full Text] [Related]
34. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction. Lee JJ; Principe LM; Fasco MJ Biochemistry; 1985 Dec; 24(25):7063-70. PubMed ID: 4084561 [TBL] [Abstract][Full Text] [Related]
35. Vitamin K-dependent carboxylase: possible artifact of analysis due to a pyridine nucleotide-dependent carboxylation. Wallin R; Suttie JW Biochem Biophys Res Commun; 1980 Jun; 94(4):1374-80. PubMed ID: 7396966 [No Abstract] [Full Text] [Related]
36. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat. Fasco MJ; Principe LM J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669 [TBL] [Abstract][Full Text] [Related]
37. Responses of renal and hepatic vitamin K dependent gamma-glutamyl carboxylase substrates to warfarin and vitamin K treatments. Karl PI; Friedman PA Int J Biochem; 1985; 17(12):1313-6. PubMed ID: 4092815 [TBL] [Abstract][Full Text] [Related]
38. Warfarin resistance in a Chicago strain of rats. Misenheimer TM; Suttie JW Biochem Pharmacol; 1990 Nov; 40(9):2079-84. PubMed ID: 2242035 [TBL] [Abstract][Full Text] [Related]